poisar

Stocks · News reference

Galmed Pharma’s Subsidiary Colospan Completes Feasibility Study Supporting Development Of Intraoperative Colon Tissue Quality Assessment Platform

BenzingaAug 19, 2026, 11:04 AMBenzinga Newsdesk

The prospective, single-arm study enrolled 32 colorectal cancer patients at three leading clinical centers in Israel. The primary objective was to demonstrate feasibility of intraoperative quantitative measurement of

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 19, 2026, 11:04 AM
Checked
Aug 19, 2026, 11:04 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading